Skip to content
Screener

Trevi Therapeutics, Inc. TRVI Offering Costs Included In Accrued Expenses

Offering Costs Included In Accrued Expenses at other companies

GTE
Gores Holdings XGTEN
$380.33K+484%
FCR
FutureCrest AcquisitionFCRS
$75K
KBO
Karbon Capital PartnersKBON
$75.37K
SBX
SBXESBXE
$85K
SCP
Social Commerce Partners CorporationSCPQ
$108.5K
SVC
Stellar V Capital Corp.SVCC
$75K

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.64B+196%
Enterprise value$2.62B+238%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept trvi:OfferingCostsIncludedInAccruedExpenses.

The source filing: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026.

Filed
Mar 17, 2026, 12:00 AM EDT
Fiscal year
FY2025
Accession
0001193125-26-110783
Line itemYear Ended December 31, 2025Year Ended December 31, 2024
Net (decrease) increase in cash and cash equivalents(15,183)1,700
Cash and cash equivalents at beginning of period34,09732,397
Cash and cash equivalents at end of period$18,914$34,097
Supplemental disclosure of cash flow information:
Interest paid$(4)
State research tax credits exchanged for cash$33$32
Supplemental disclosure of non-cash financing activities:
Offering costs included in accrued expenses$233

Item 16. Form 10-K Summary

FAQ

What is Trevi Therapeutics, Inc.'s offering costs included in accrued expenses?
Trevi Therapeutics, Inc. (TRVI) reported offering costs included in accrued expenses of $58.25K in Q4 2024.
What is the long-term trend for Trevi Therapeutics, Inc.'s offering costs included in accrued expenses?
Over 2 years (2021 to 2024), Trevi Therapeutics, Inc.'s offering costs included in accrued expenses has grown at a 138.4% compound annual growth rate (CAGR), from $41K to $233K.
What does offering costs included in accrued expenses mean?
Captures the portion of costs related to equity or debt offerings that have been incurred but not yet paid in cash. These costs are recognized as liabilities on the balance sheet until settlement. Tracking this helps investors understand the total cost of capital-raising activities beyond immediate cash outflows.

Ask your AI about Trevi Therapeutics, Inc.'s offering costs included in accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude